CORDIS · 201525 · FP7
AUTOCAST Automatic Cancer Screening Based on Real-time PCR
Coordinator: GENOID MOLEKULARBIOLOGIAI KUTATO, GYARTO ES EGESZSEGUGYI SZOLGALATO KFT (HU)
Cancer accounts for nearly one-quarter of deaths in the developed world, exceeded only by heart diseases. One of the key strategies in cancer prevention is early diagnosis through cancer screening programs. Estimates of the premature deaths that could have been avoided through cancer screening vary from 3% to 35%, depending on a variety of assumptions. Beyond the potential to reduce mortality, screening may reduce cancer morbidity since treatment for earlier-stage cancers is often less aggressive than that for more advanced-stage cancers. Currently many of these screening programs, have issue…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
Co-funding: the European Union contributes €3.0M toward a total project budget of €4.1M — a funding rate of 72%, with the remainder covered by the consortium partners. The project runs over approximately 3.5 years from 2008-08-01 to 2012-01-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from HU
see all →- HCEMM — Establishing the Hungarian Center of Excellence for Molecular Medicine in partnership with EMBL739593 · H2020 · €15.0M
- EPIC — Centre of Excellence in Production Informatics and Control739592 · H2020 · €10.9M
- DYNASNET — Dynamics and Structure of Networks810115 · H2020 · €9.3M
- DALIA — Danube Region Water Lighthouse Action101094070 · HORIZON · €8.5M
- DETERMINISTIC6G — DETERMINISTIC E2E COMMUNICATION WITH 6G101096504 · HORIZON · €5.5M
- MOMENTUM PPDF — Momentum Premium Postdoctoral fellowship101179854 · HORIZON · €5.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-FP funding scheme.
- What is the EU contribution?
- The European Commission contributes €3.0M toward a total project budget of €4.1M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by GENOID MOLEKULARBIOLOGIAI KUTATO, GYARTO ES EGESZSEGUGYI SZOLGALATO KFT (HU).
- What is the project timeline?
- The project runs from 2008-08-01 to 2012-01-31 — approximately 3.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 201525.